Expression of IL‐17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|16|1844-1856

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.16, 2015-12, pp. : 1844-1856

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteopontin Expression in Prostate Cancer and Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 62, Iss. 3, 1999-10 ,pp. : 155-158

Karger

Access to resources Recommend Favorite

Oxidative Stress in Benign Prostatic Hyperplasia and Prostate Cancer

By  

Urologia Internationalis, Vol. 85, Iss. 3, 2010-05 ,pp. : 328-333

Karger

Access to resources Recommend Favorite

ROLE OF ESTROGENS IN HUMAN BENIGN PROSTATIC HYPERPLASIA

By Sciarra F.   Toscano V.  

Archives of Andrology, Vol. 44, Iss. 3, 2000-05 ,pp. : 213-220

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Clinical Value of Complexed PSA and Total PSA in the Discrimination between Benign Prostatic Hyperplasia and Prostate Cancer

By  

Urologia Internationalis, Vol. 76, Iss. 1, 2006-01 ,pp. : 27-30

Karger

Access to resources Recommend Favorite

Tadalafil Monotherapy for Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-08 ,pp. : 487-488

Karger

Access to resources Recommend Favorite